Insider trades
Praveen P. Tipirneni, Director of BridgeBio Oncology Therapeutics BBOT, has filed 0 purchases and 12 sales on the open market. The latest trade was on 06/16.
Praveen P. Tipirneni
Director
- First filing
- 23/01/18
- Trades
- 54 trades
- Buys / sales
- 0 / 12
- 12-month net buying
- No record
- Last trade
- 06/16
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 24/07/08 | 24/07/10 | 21,582 sh | $55.79 | $1,204,059.78 | −33.7% | |
| Open-market sale | 24/01/16 | 24/01/17 | 13,923 sh | $27.49 | $382,743.27 | −24.9% | |
| Open-market sale | 23/08/01 | 23/08/03 | 3,597 sh3 trades | $57.04avg. | $205,183.5 | −20.5% | |
| Open-market sale | 23/07/03 | 23/07/06 | 3,597 sh | $57.04 | $205,172.88 | −20.5% | |
| Open-market sale | 23/06/12 | 23/06/14 | 840 sh | $63.01 | $52,928.4 | −5.7% | |
| Open-market sale | 23/06/01 | 23/06/02 | 3,597 sh2 trades | $57.14avg. | $205,522 | −20.5% | |
| Open-market sale | 23/05/03 | 23/05/05 | 3,597 sh | $51.11 | $183,842.67 | −20.5% | |
| Open-market sale | 23/04/25 | 23/04/27 | 25,179 sh | $53.40 | $1,344,558.6 | −64.4% | |
| Open-market sale | 23/01/14 | 23/01/18 | 4,027 sh | $30.63 | $123,347.01 | −24.1% |